An update on statistical modeling for quality risk assessment of clinical trials
View ORCID ProfileBjörn Koneswarakantha, View ORCID ProfileTimothé Ménard
doi: https://doi.org/10.1101/2021.07.12.21260214
Björn Koneswarakantha
1F. Hoffmann-La Roche AG - CH-4070, Basel, Switzerland
PhDTimothé Ménard
1F. Hoffmann-La Roche AG - CH-4070, Basel, Switzerland
PharmDData Availability
Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
https://github.com/openpharma/quality_risk_assesment_clinical_trials
Posted October 11, 2021.
An update on statistical modeling for quality risk assessment of clinical trials
Björn Koneswarakantha, Timothé Ménard
medRxiv 2021.07.12.21260214; doi: https://doi.org/10.1101/2021.07.12.21260214
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)